
An Introduction to Pharmacovigilance
Wiley (Publisher)
2nd Edition
Published on 26. April 2017
Book
Paperback/Softback
192 pages
978-1-119-28974-6 (ISBN)
Description
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.
This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance.
Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance.
This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance.
Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance.
More details
Edition
2nd edition
Language
English
Place of publication
Hoboken
United Kingdom
Publishing group
John Wiley and Sons Ltd
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 216 mm
Width: 140 mm
Thickness: 11 mm
Weight
249 gr
ISBN-13
978-1-119-28974-6 (9781119289746)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

Patrick Waller | Mira Harrison-Woolrych
An Introduction to Pharmacovigilance
E-Book
02/2017
2nd Edition
Wiley-Blackwell
€36.99
Available for download

Patrick Waller | Mira Harrison-Woolrych
An Introduction to Pharmacovigilance
E-Book
02/2017
2nd Edition
Wiley-Blackwell
€36.99
Available for download
Previous edition

Patrick Waller
An Introduction to Pharmacovigilance
Book
10/2009
Wiley-Blackwell
€41.90
Article exhausted; check for reprint
Persons
Patrick Waller MD, MPH, FRCPEd, FFPM, Formerly Honorary Professor, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Mira Harrison-Woolrych BM, DM, DFFP, FRCOG, Honorary Research Associate Professor, Dunedin School of Medicine, University of Otago, New Zealand; Senior Medical Assessor, Vigilance and Risk Management, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK and Secretary General of the International Society of Pharmacovigilance (ISoP).
Mira Harrison-Woolrych BM, DM, DFFP, FRCOG, Honorary Research Associate Professor, Dunedin School of Medicine, University of Otago, New Zealand; Senior Medical Assessor, Vigilance and Risk Management, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK and Secretary General of the International Society of Pharmacovigilance (ISoP).
Author
Consultant in Pharmacovigilance and Pharmacoepidemiology, Southampton, UK
Content
Foreword ix
Preface to the Second Edition xi
Preface to the First Edition xiii
Acknowledgements xv
List of Abbreviations xvii
1 What is Pharmacovigilance and How Has it Developed? 1
2 Basic Concepts 19
3 Types and Sources of Data 37
4 The Process of Pharmacovigilance 55
5 Regulatory Aspects of Pharmacovigilance 75
6 International Collaboration 95
7 Clinical Aspects of Adverse Drug Reactions 109
8 Ethical and Societal Considerations 123
9 Future Directions 135
10 Learning More About Pharmacovigilance 145
Glossary 151
Index 157
Preface to the Second Edition xi
Preface to the First Edition xiii
Acknowledgements xv
List of Abbreviations xvii
1 What is Pharmacovigilance and How Has it Developed? 1
2 Basic Concepts 19
3 Types and Sources of Data 37
4 The Process of Pharmacovigilance 55
5 Regulatory Aspects of Pharmacovigilance 75
6 International Collaboration 95
7 Clinical Aspects of Adverse Drug Reactions 109
8 Ethical and Societal Considerations 123
9 Future Directions 135
10 Learning More About Pharmacovigilance 145
Glossary 151
Index 157